Risk of malignancy in rheumatoid arthritis patients initiating biologics: an historical propensity score matched cohort study within the French nationwide healthcare database.
Raphaèle SerorAlexandre LafourcadeYann De RyckeSandrine PintoJohann CastanedaBruno FautrelXavier MarietteFlorence TubachPublished in: RMD open (2022)
In this historical cohort study within the French nationwide healthcare database, the risk of overall, solid or haematological malignancies did not significantly differ between patients with RA initiating bDMARD and those continuing csDMARDs.